Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification

Narayan Shivapurkar, Jyotsna Reddy, Hittu Matta, Ubaradka G. Sathyanarayana, C. X. Huang, Shinichi Toyooka, John D. Minna, Preet M. Chaudhary, Adi F. Gazdar

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

We have previously reported that the key apoptosis related gene caspase 8 (CASP8) is frequently silenced in small cell lung cancer (SCLC) tumors and cell lines usually, but not always, by aberrant promoter methylation. Because CASP8 is a key component of the death-inducing signaling complex (DISC) when specific death receptors (including DR4, DR5, FAS) are activated by their specific ligands (TRAIL/FASL), we examined expression of the components of the DISC complex in lung cancer cell lines. MYC family members are frequently amplified (MYC + ve) in SCLC, and MYC is a potent inducer of apoptosis. We examined 34 SCLC lines (12 of which were MYC + ve) and 22 NSCLC lines. CASP8 gene expression was frequently lost (79%) at message and protein levels in SCLC but not in non-SCLC (NSCLC). MYC amplification was present in 45% of SCLC cell lines, which had lost CASP8 expression, but not in any of the CASP8 positive lines. The frequency of CASP8 loss was significantly higher in MYC + ve SCLC compared to MYC - ve SCLC or in NSCLC. Analyses of other DISC components showed significantly higher rates of loss of expression of CASP10, DR5, FAS and FASL in SCLC compared to NSCLC. The loss of expression of proapoptotic DISC components was significantly higher in MYC + ve SCLC cell lines and these lines were completely resistant to TRAIL. Expression of CASP10 (a caspase closely related to CASP8) was frequently absent at the protein level in both SCLC and NSCLC lines. Expression of c-FLIP (proteolytically inactive homolog of CASP8) was inversely related to expression of CASP8. Our major conclusions are: (a) The death receptor pathway is differently inactivated at multiple levels in lung cancer cell lines; and (b) MYC amplification in SCLC is associated with inactivation of most components of the DISC complex, with resistance to TRAIL and with expression of c-FLIP. These findings may have considerable clinical and therapeutic implications.

Original languageEnglish (US)
Pages (from-to)8510-8514
Number of pages5
JournalOncogene
Volume21
Issue number55
DOIs
StatePublished - Dec 5 2002

Fingerprint

Death Domain Receptor Signaling Adaptor Proteins
Small Cell Lung Carcinoma
Caspase 8
Lung Neoplasms
Cell Line
Death Domain Receptors
Non-Small Cell Lung Carcinoma
Apoptosis
Caspases
Tumor Cell Line
Methylation
Proteins

Keywords

  • CASP8
  • DISC
  • MYC
  • TRAIL

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Shivapurkar, N., Reddy, J., Matta, H., Sathyanarayana, U. G., Huang, C. X., Toyooka, S., ... Gazdar, A. F. (2002). Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. Oncogene, 21(55), 8510-8514. https://doi.org/10.1038/sj.onc.1205941

Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. / Shivapurkar, Narayan; Reddy, Jyotsna; Matta, Hittu; Sathyanarayana, Ubaradka G.; Huang, C. X.; Toyooka, Shinichi; Minna, John D.; Chaudhary, Preet M.; Gazdar, Adi F.

In: Oncogene, Vol. 21, No. 55, 05.12.2002, p. 8510-8514.

Research output: Contribution to journalArticle

Shivapurkar, N, Reddy, J, Matta, H, Sathyanarayana, UG, Huang, CX, Toyooka, S, Minna, JD, Chaudhary, PM & Gazdar, AF 2002, 'Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification', Oncogene, vol. 21, no. 55, pp. 8510-8514. https://doi.org/10.1038/sj.onc.1205941
Shivapurkar, Narayan ; Reddy, Jyotsna ; Matta, Hittu ; Sathyanarayana, Ubaradka G. ; Huang, C. X. ; Toyooka, Shinichi ; Minna, John D. ; Chaudhary, Preet M. ; Gazdar, Adi F. / Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. In: Oncogene. 2002 ; Vol. 21, No. 55. pp. 8510-8514.
@article{0a7c57d7942742db9644e7d1da41cfcd,
title = "Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification",
abstract = "We have previously reported that the key apoptosis related gene caspase 8 (CASP8) is frequently silenced in small cell lung cancer (SCLC) tumors and cell lines usually, but not always, by aberrant promoter methylation. Because CASP8 is a key component of the death-inducing signaling complex (DISC) when specific death receptors (including DR4, DR5, FAS) are activated by their specific ligands (TRAIL/FASL), we examined expression of the components of the DISC complex in lung cancer cell lines. MYC family members are frequently amplified (MYC + ve) in SCLC, and MYC is a potent inducer of apoptosis. We examined 34 SCLC lines (12 of which were MYC + ve) and 22 NSCLC lines. CASP8 gene expression was frequently lost (79{\%}) at message and protein levels in SCLC but not in non-SCLC (NSCLC). MYC amplification was present in 45{\%} of SCLC cell lines, which had lost CASP8 expression, but not in any of the CASP8 positive lines. The frequency of CASP8 loss was significantly higher in MYC + ve SCLC compared to MYC - ve SCLC or in NSCLC. Analyses of other DISC components showed significantly higher rates of loss of expression of CASP10, DR5, FAS and FASL in SCLC compared to NSCLC. The loss of expression of proapoptotic DISC components was significantly higher in MYC + ve SCLC cell lines and these lines were completely resistant to TRAIL. Expression of CASP10 (a caspase closely related to CASP8) was frequently absent at the protein level in both SCLC and NSCLC lines. Expression of c-FLIP (proteolytically inactive homolog of CASP8) was inversely related to expression of CASP8. Our major conclusions are: (a) The death receptor pathway is differently inactivated at multiple levels in lung cancer cell lines; and (b) MYC amplification in SCLC is associated with inactivation of most components of the DISC complex, with resistance to TRAIL and with expression of c-FLIP. These findings may have considerable clinical and therapeutic implications.",
keywords = "CASP8, DISC, MYC, TRAIL",
author = "Narayan Shivapurkar and Jyotsna Reddy and Hittu Matta and Sathyanarayana, {Ubaradka G.} and Huang, {C. X.} and Shinichi Toyooka and Minna, {John D.} and Chaudhary, {Preet M.} and Gazdar, {Adi F.}",
year = "2002",
month = "12",
day = "5",
doi = "10.1038/sj.onc.1205941",
language = "English (US)",
volume = "21",
pages = "8510--8514",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "55",

}

TY - JOUR

T1 - Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification

AU - Shivapurkar, Narayan

AU - Reddy, Jyotsna

AU - Matta, Hittu

AU - Sathyanarayana, Ubaradka G.

AU - Huang, C. X.

AU - Toyooka, Shinichi

AU - Minna, John D.

AU - Chaudhary, Preet M.

AU - Gazdar, Adi F.

PY - 2002/12/5

Y1 - 2002/12/5

N2 - We have previously reported that the key apoptosis related gene caspase 8 (CASP8) is frequently silenced in small cell lung cancer (SCLC) tumors and cell lines usually, but not always, by aberrant promoter methylation. Because CASP8 is a key component of the death-inducing signaling complex (DISC) when specific death receptors (including DR4, DR5, FAS) are activated by their specific ligands (TRAIL/FASL), we examined expression of the components of the DISC complex in lung cancer cell lines. MYC family members are frequently amplified (MYC + ve) in SCLC, and MYC is a potent inducer of apoptosis. We examined 34 SCLC lines (12 of which were MYC + ve) and 22 NSCLC lines. CASP8 gene expression was frequently lost (79%) at message and protein levels in SCLC but not in non-SCLC (NSCLC). MYC amplification was present in 45% of SCLC cell lines, which had lost CASP8 expression, but not in any of the CASP8 positive lines. The frequency of CASP8 loss was significantly higher in MYC + ve SCLC compared to MYC - ve SCLC or in NSCLC. Analyses of other DISC components showed significantly higher rates of loss of expression of CASP10, DR5, FAS and FASL in SCLC compared to NSCLC. The loss of expression of proapoptotic DISC components was significantly higher in MYC + ve SCLC cell lines and these lines were completely resistant to TRAIL. Expression of CASP10 (a caspase closely related to CASP8) was frequently absent at the protein level in both SCLC and NSCLC lines. Expression of c-FLIP (proteolytically inactive homolog of CASP8) was inversely related to expression of CASP8. Our major conclusions are: (a) The death receptor pathway is differently inactivated at multiple levels in lung cancer cell lines; and (b) MYC amplification in SCLC is associated with inactivation of most components of the DISC complex, with resistance to TRAIL and with expression of c-FLIP. These findings may have considerable clinical and therapeutic implications.

AB - We have previously reported that the key apoptosis related gene caspase 8 (CASP8) is frequently silenced in small cell lung cancer (SCLC) tumors and cell lines usually, but not always, by aberrant promoter methylation. Because CASP8 is a key component of the death-inducing signaling complex (DISC) when specific death receptors (including DR4, DR5, FAS) are activated by their specific ligands (TRAIL/FASL), we examined expression of the components of the DISC complex in lung cancer cell lines. MYC family members are frequently amplified (MYC + ve) in SCLC, and MYC is a potent inducer of apoptosis. We examined 34 SCLC lines (12 of which were MYC + ve) and 22 NSCLC lines. CASP8 gene expression was frequently lost (79%) at message and protein levels in SCLC but not in non-SCLC (NSCLC). MYC amplification was present in 45% of SCLC cell lines, which had lost CASP8 expression, but not in any of the CASP8 positive lines. The frequency of CASP8 loss was significantly higher in MYC + ve SCLC compared to MYC - ve SCLC or in NSCLC. Analyses of other DISC components showed significantly higher rates of loss of expression of CASP10, DR5, FAS and FASL in SCLC compared to NSCLC. The loss of expression of proapoptotic DISC components was significantly higher in MYC + ve SCLC cell lines and these lines were completely resistant to TRAIL. Expression of CASP10 (a caspase closely related to CASP8) was frequently absent at the protein level in both SCLC and NSCLC lines. Expression of c-FLIP (proteolytically inactive homolog of CASP8) was inversely related to expression of CASP8. Our major conclusions are: (a) The death receptor pathway is differently inactivated at multiple levels in lung cancer cell lines; and (b) MYC amplification in SCLC is associated with inactivation of most components of the DISC complex, with resistance to TRAIL and with expression of c-FLIP. These findings may have considerable clinical and therapeutic implications.

KW - CASP8

KW - DISC

KW - MYC

KW - TRAIL

UR - http://www.scopus.com/inward/record.url?scp=0037028250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037028250&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1205941

DO - 10.1038/sj.onc.1205941

M3 - Article

C2 - 12466971

AN - SCOPUS:0037028250

VL - 21

SP - 8510

EP - 8514

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 55

ER -